Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,700,000 | 1,671,000 | 104,000 | 347,000 | -239,000 |
| Depreciation Amortization | 1,116,000 | 929,000 | 848,000 | 826,000 | 788,000 |
| Income taxes - deferred | -4,301,000 | -87,000 | 245,000 | -305,000 | -532,000 |
| Accounts receivable | -130,000 | -110,000 | -30,000 | -216,000 | -17,000 |
| Other Working Capital | -296,000 | -2,169,000 | 66,000 | 206,000 | 326,000 |
| Other Operating Activity | 747,000 | 76,000 | 193,000 | 324,000 | 365,000 |
| Operating Cash Flow | $1,836,000 | $310,000 | $1,426,000 | $1,182,000 | $691,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -454,000 | -302,000 | -319,000 | -347,000 | -247,000 |
| Net Acquisitions | -4,292,000 | -1,448,000 | -560,000 | -408,000 | -1,734,000 |
| Purchase Of Investment | -149,000 | -172,000 | -131,000 | -132,000 | -266,000 |
| Other Investing Activity | -146,000 | 1,000 | 0 | 0 | 61,000 |
| Investing Cash Flow | $-5,041,000 | $-1,921,000 | $-1,010,000 | $-887,000 | $-2,186,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 125,000 | 1,589,000 | 3,339,000 | 630,000 | 565,000 |
| Debt Issued | 7,229,000 | 987,000 | N/A | N/A | 2,535,000 |
| Debt Repayment | -3,560,000 | -602,000 | -1,000,000 | -315,000 | -1,150,000 |
| Common Stock Issued | 123,000 | 101,000 | 85,000 | 111,000 | 114,000 |
| Other Financing Activity | -944,000 | -643,000 | -2,314,000 | -632,000 | -788,000 |
| Financing Cash Flow | $2,973,000 | $1,432,000 | $110,000 | $-206,000 | $1,276,000 |
| Exchange Rate Effect | 10,000 | -8,000 | 4,000 | -2,000 | -4,000 |
| Beginning Cash Position | 829,000 | 1,017,000 | 487,000 | 400,000 | 623,000 |
| End Cash Position | 607,000 | 829,000 | 1,017,000 | 487,000 | 400,000 |
| Net Cash Flow | $-222,000 | $-188,000 | $530,000 | $87,000 | $-223,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,836,000 | 310,000 | 1,426,000 | 1,182,000 | 691,000 |
| Capital Expenditure | -461,000 | -316,000 | -319,000 | -376,000 | -247,000 |
| Free Cash Flow | 1,375,000 | -6,000 | 1,107,000 | 806,000 | 444,000 |